272 related articles for article (PubMed ID: 29078078)
1. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.
Talarico LB; Byrne AB; Amarilla S; Lovera D; Vázquez C; Chamorro G; Acosta PL; Ferretti A; Caballero MT; Arbo A; Polack FP
J Clin Virol; 2017 Dec; 97():10-17. PubMed ID: 29078078
[TBL] [Abstract][Full Text] [Related]
2. Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.
Upasani V; Scagnolari C; Frasca F; Smith N; Bondet V; Vanderlinden A; Lay S; Auerswald H; Heng S; Laurent D; Ly S; Duong V; Antonelli G; Dussart P; Duffy D; Cantaert T
Front Immunol; 2020; 11():605087. PubMed ID: 33391269
[TBL] [Abstract][Full Text] [Related]
3. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity.
Pichyangkul S; Endy TP; Kalayanarooj S; Nisalak A; Yongvanitchit K; Green S; Rothman AL; Ennis FA; Libraty DH
J Immunol; 2003 Nov; 171(10):5571-8. PubMed ID: 14607965
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype.
Ngwe Tun MM; Kyaw AK; Makki N; Muthugala R; Nabeshima T; Inoue S; Hayasaka D; Moi ML; Buerano CC; Thwe SM; Thant KZ; Morita K
Infect Genet Evol; 2016 Sep; 43():31-7. PubMed ID: 27154331
[TBL] [Abstract][Full Text] [Related]
5. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.
Chen HW; King K; Tu J; Sanchez M; Luster AD; Shresta S
J Immunol; 2013 Oct; 191(8):4194-201. PubMed ID: 24043884
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of primary and secondary dengue in Paraguay and its relation to virus serotype.
Lovera D; Martínez-Cuellar C; Galeano F; Amarilla S; Vazquez C; Arbo A
J Infect Dev Ctries; 2019 Dec; 13(12):1127-1134. PubMed ID: 32088700
[TBL] [Abstract][Full Text] [Related]
7. Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase.
Oliveira RA; Silva MM; Calzavara-Silva CE; Silva AM; Cordeiro MT; Moura PM; Baptista PN; Marques ET; Gil LH
Mem Inst Oswaldo Cruz; 2016 May; 111(6):378-84. PubMed ID: 27223651
[TBL] [Abstract][Full Text] [Related]
8. Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.
Castillo Ramirez JA; Urcuqui-Inchima S
J Interferon Cytokine Res; 2015 Jun; 35(6):421-30. PubMed ID: 25629430
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection.
Kayesh MEH; Kitab B; Sanada T; Hayasaka D; Morita K; Kohara M; Tsukiyama-Kohara K
Infect Genet Evol; 2017 Jul; 51():203-210. PubMed ID: 28392469
[TBL] [Abstract][Full Text] [Related]
10. Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients.
Terzian ACB; Schanoski AS; Mota MTO; da Silva RA; Estofolete CF; Colombo TE; Rahal P; Hanley KA; Vasilakis N; Kalil J; Nogueira ML
Clin Infect Dis; 2017 Oct; 65(8):1260-1265. PubMed ID: 29017246
[TBL] [Abstract][Full Text] [Related]
11. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
Kitab B; Kohara M; Tsukiyama-Kohara K
Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
[TBL] [Abstract][Full Text] [Related]
12. Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production.
Becquart P; Wauquier N; Nkoghe D; Ndjoyi-Mbiguino A; Padilla C; Souris M; Leroy EM
BMC Infect Dis; 2010 Dec; 10():356. PubMed ID: 21167041
[TBL] [Abstract][Full Text] [Related]
13. Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level.
Pal T; Dutta SK; Mandal S; Saha B; Tripathi A
J Clin Virol; 2014 Nov; 61(3):365-70. PubMed ID: 25288310
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated cytokine storm and its role in severe dengue.
Srikiatkhachorn A; Mathew A; Rothman AL
Semin Immunopathol; 2017 Jul; 39(5):563-574. PubMed ID: 28401256
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
16. Callithrix penicillata: a feasible experimental model for dengue virus infection.
Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
[TBL] [Abstract][Full Text] [Related]
17. Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.
Simon-Lorière E; Duong V; Tawfik A; Ung S; Ly S; Casadémont I; Prot M; Courtejoie N; Bleakley K; Buchy P; Tarantola A; Dussart P; Cantaert T; Sakuntabhai A
Sci Transl Med; 2017 Aug; 9(405):. PubMed ID: 28855396
[TBL] [Abstract][Full Text] [Related]
18. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
19. Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients.
Pradeep SP; Hoovina Venkatesh P; Manchala NR; Vayal Veedu A; Basavaraju RK; Selvasundari L; Ramakrishna M; Chandrakiran Y; Krishnamurthy V; Holigi S; Thomas T; Ross CR; Dias M; Satchidanandam V
Front Immunol; 2021; 12():677874. PubMed ID: 34335578
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of CD4
Manh DH; Weiss LN; Thuong NV; Mizukami S; Dumre SP; Luong QC; Thanh LC; Thang CM; Huu PT; Phuc LH; Nhung CTH; Mai NT; Truong NQ; Ngu VTT; Quoc DK; Ha TTN; Ton T; An TV; Halhouli O; Quynh LN; Kamel MG; Karbwang J; Huong VTQ; Huy NT; Hirayama K
Front Immunol; 2020; 11():1980. PubMed ID: 33072068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
